‘Miraculous’ cancer breakthrough as a groundbreaking new blood test that could save THOUSANDS of lives is coming to Australia – and it can even treat terminal patients
- Cancer patients now have access to tumor DNA testing in Melbourne
- The test, known as ctDNA, could replace biopsies with a simple blood sample
- Bruce Davis was on his death bed when he was treated after a ctDNA test
- The cardiothoracic surgeon improved at night and is now in remission
A new blood test is being conducted in Australia that can save thousands of terminal cancer patients.
Cancer patients now have access to tumor DNA tests at the Peter MacCallum Cancer Center in Melbourne as part of new clinical studies.
The breakthrough tests, known as circulating tumor DNA research, or ctDNA, can mean defeating previously untreatable cancers, giving thousands of families the much-needed lifeline.
Melbourne cardiothoracic surgeon Bruce Davis, who was diagnosed with t-cell lymphoma in 2013, owes his life to the groundbreaking blood test.
He underwent a series of chemotherapy and immunotherapy treatments, but the disease came back and spread to his stomach and brain.
When he received ctDNA tests, he was just days after death.
Hematologists Piers Blombery (photo) said the treatment is helpful for people with cancer that’s deep in the brain – and who can treat previously incurable tumors
WHAT IS THE CIRCULATION OF DNA TESTS?
Circulating tumor DNA are pieces of DNA secreted by cancer cells.
By isolating the DNA via a blood test, specialists can receive an accurate diagnosis and personalize treatment options.
It replaces the need for invasive biopsies and is more effective in determining diagnosis, prognosis and treatment options.
Doctors can also use genomic sequencing to understand any DNA changes that have taken place and what is causing cancer growth.
Treatments can therefore be individually adjusted and further blood tests can monitor effectiveness.
Source: the Australian
Hematologists were able to isolate proteins commonly associated with melanoma as a result of the ctDNA test and developed a treatment to target the protein and attack the cancer.
Professor Miles Prince was one of the doctors who treated Mr. Davis and said that he deteriorated quickly before treatment.
“Incredibly, we gave him a certain medicine, he had a huge fever and it was almost like the movies – he woke up the next day as a new person,” he said. The Australian.
Mr. Davis is now in remission, saying the drug had a “miraculous effect.”
Leading hematologists Piers Blombery said the treatment is especially helpful for people with cancer in areas where a biopsy cannot be done, such as deep in the brain.
The test replaces the need for biopsies by using a blood sample to test the DNA of cancer tumors, providing a more accurate diagnosis and enabling personalized treatment options.
“Every cancer is different, and genomics tests like the ctDNA panel give clinicians more details about what drives the individual patient’s tumor cells.
“It can give you more accurate diagnoses, forecasts, and ultimately more treatment options.”
Professor Prince’s test could monitor how cancer patients respond to treatments, such as blood glucose monitoring in diabetics, and prevent people from receiving the wrong treatments.
He has campaigned with the federal government to fund the tests, claiming it can save lives every day.
Cancer survivor Brice Davis (left) is standing next to Professor Miles Prince – one of the doctors who saves his life using ctDNA tests